GNH USA

Europe — EMA

Oliclinomel N7-1000e

GNH USA supplies Oliclinomel N7-1000e (amino acid solution), a parenteral nutrition product for patients unable to receive enteral feeding. Request a quote.

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin

Request sourcing

1
Pack/s

What is Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin?

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Oliclinomel N7-1000e, is an amino acid solution presented as a solution for injection for intravenous use. It provides essential and non‑essential amino acids to support protein synthesis and nitrogen balance in patients requiring parenteral nutrition, such as those in critical care, postoperative or trauma settings.

GNH USA supplies Oliclinomel N7-1000e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin used for?

Oliclinomel N7-1000e is an amino acid solution used in parenteral nutrition to support protein synthesis and nitrogen balance. - Parenteral nutrition for patients unable to receive enteral feeding: supplies a complete amino acid profile to maintain nitrogen balance. - Post‑operative or trauma patients requiring amino acid supplementation: supports wound healing and muscle recovery. - Critical care patients with increased protein needs: helps meet elevated metabolic demands during intensive care.

What are the side effects of Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin?

Adverse reactions may occur with intravenous amino acid solutions and should be monitored.

Common Side Effects: - Infusion site erythema or pain: mild local irritation during administration. - Nausea or vomiting: transient gastrointestinal discomfort. - Transient hyperammonemia: mild elevation of blood ammonia levels. - Mild electrolyte disturbances: changes in serum potassium or calcium. - Low‑grade fever: temporary rise in body temperature.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical intervention. - Metabolic acidosis: significant pH imbalance in blood. - Hyperglycemia: marked increase in blood glucose levels. - Renal dysfunction: impaired kidney function in susceptible patients. - Hepatic dysfunction: liver enzyme elevations indicating stress. - Thrombophlebitis: inflammation of veins at the infusion site.

What precautions apply to Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin?

When using Oliclinomel N7-1000e, clinicians should consider several safety measures. - Renal impairment: monitor renal function and adjust infusion rate as needed. - Hepatic dysfunction: assess liver enzymes before and during therapy. - Electrolyte balance: check serum electrolytes regularly to detect shifts. - Metabolic disorders: watch for signs of hyperammonemia or acidosis. - Allergy: discontinue infusion immediately if hypersensitivity reactions develop. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin interact with?

Amino acid solutions can interact with other intravenous therapies and systemic medications.

Major Interactions (Avoid): - Concurrent high‑dose amino acid solutions: risk of nitrogen overload and metabolic imbalance. - Incompatible IV solutions (e.g., calcium chloride): may precipitate and cause catheter blockage. - Certain chemotherapeutic agents: can alter amino acid metabolism and increase toxicity.

Moderate Interactions (Monitor Closely): - Insulin or hypoglycemic agents: may require dose adjustment due to glucose fluctuations. - Diuretics: can affect electrolyte status and necessitate monitoring. - Renal replacement therapy: may remove administered amino acids, reducing efficacy.

Frequently asked questions

What is Oliclinomel N7-1000e used for?+
Oliclinomel N7-1000e is an intravenous amino acid solution used as part of parenteral nutrition. It supplies essential and non‑essential amino acids to patients who cannot receive enteral feeding, supporting protein synthesis, nitrogen balance, and metabolic needs in critical care, postoperative, or trauma settings.
How does the amino acid mixture in Oliclinomel N7-1000e work?+
The mixture provides a balanced set of amino acids that are directly absorbed into the bloodstream. Cells transport these amino acids into the cytoplasm, where they are incorporated into new proteins, supporting tissue repair, enzyme production, and overall metabolic functions required during periods of increased physiological stress.
What is the usual dose of Oliclinomel N7-1000e?+
The dose of Oliclinomel N7-1000e is individualized and determined by the prescribing clinician based on the patient’s weight, clinical condition, renal and hepatic function, and overall nutritional requirements. No fixed regimen is provided in public information.
Is Oliclinomel N7-1000e safe during pregnancy or breastfeeding?+
Safety data for Oliclinomel N7-1000e in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Oliclinomel N7-1000e from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and any required import documentation.
How does Oliclinomel N7-1000e compare with other parenteral amino acid products?+
Oliclinomel N7-1000e offers a comprehensive profile of ten essential and non‑essential amino acids in a single solution, matching the composition of many standard parenteral amino acid formulations. Compared with products that contain fewer amino acids or require mixing, it simplifies preparation and may reduce the risk of dosing errors.
What are the storage and handling requirements for Oliclinomel N7-1000e?+
The solution should be stored at 2‑8 °C, protected from light, and kept in its original container. It must not be frozen or shaken vigorously. Before use, inspect for particulate matter or discoloration and allow the product to reach room temperature if required by the administration protocol.
How is Oliclinomel N7-1000e administered?+
Oliclinomel N7-1000e is administered intravenously, typically via a dedicated infusion line. The infusion rate is set by the prescriber based on the patient’s nutritional needs and clinical status, and the solution is delivered using standard aseptic techniques and infusion pumps where appropriate.
What are the most serious risks associated with Oliclinomel N7-1000e?+
Serious risks include anaphylactic reactions, metabolic acidosis, severe hyperglycemia, renal or hepatic dysfunction, and thrombophlebitis at the infusion site. Prompt recognition and management of these events are essential, and patients should be monitored closely during and after infusion.
Who should not receive Oliclinomel N7-1000e?+
Patients with known hypersensitivity to any of the amino acids in the formulation, those with uncontrolled metabolic disorders such as severe hepatic or renal failure, and individuals for whom a compatible intravenous solution cannot be ensured should not receive Oliclinomel N7-1000e. Clinical judgment is required for each case.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin
Route
Intravenous Use
Manufacturer
Baxter Healthcare Ltd.
Origin
EU